Out of those, 119 were initial diagnoses, comprising 56 patients with newly diagnosed glioblastoma WHO 4 and 11 patients with newly diagnosed glioma WHO 2 at the time of TSPO-PET. This evidence concerns the gene TSPO and glioma.